Translate Bio Inc reports results for the quarter ended in June - Earnings Summary

Telesis Bio

06/08/2021 24:12

* Translate Bio Inc  TBIO.OQ  reported quarterly adjusted
earnings of 21 cents​​ per share for the quarter ended in June.
The mean expectation of nine analysts for the quarter was for a
loss of 23 cents per share.
* Revenue rose 345.2% to $72.65 million from a year ago; 
analysts expected $31.81 million. 
* Translate Bio Inc's reported EPS for the quarter was 21
cents​.
* The mean earnings estimate of analysts had risen by
about 12.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Translate Bio Inc shares had risen by 37.4% this quarter and
gained 105.4% so far this year.
* The company reported quarterly net income of $17.14 million.
* Wall Street's median 12-month price target for Translate Bio
Inc is $38.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 11:12 p.m.  ​All
figures in US dollars unless otherwise stated